Aristotle University Of Thessaloniki (AUTH)
Διερεύνηση του ρόλου του μεταγραφικού παράγοντα FKLF1 στον αιμοποιητικό και άλλους ιστούς
Abstract
dc:descriptionFKLF1 is a transcription factor of the Krüpel-Like Factors (KLF) family, which includes factors with important identified roles in hemopoietic and most other tissues examined. Among them EKLF, which is necessary for the fetal to adult hemoglobin switching and TIEG1, a close relative of FKLF1, that participates in bone formation and has anti-proliferative effects and reduced levels in breast and prostate cancer. In previous studies FKLF1 has been shown to be involved in TGF-β1’s apoptotic and anti-proliferative pathway. Its over-expression in pancreatic cells leads to inhibition of their growth and to transcriptional activation of the pro-insulin gene. Ηowever, only a minor role of one of its gene polymorphisms has been identified in diabetes. It may also have a role in bone disease, such as osteopenia and osteoporosis and in hypertrophic cardiomyopathy. FKLF1 is capable of inducing the ε, γ and, less, β globin gene promoters in cell lines, in vitro. It may also have anti-oncogenic actions in breast and prostate cancer. Our study examined its function in four ways: a) By inserting it, though a retroviral vector in cell lines and hemopoietic progenitors, the latter examined by cell culture, in vitro and in mouse transplantation experiments in vivo. b) In mouse gene knockout and c) transgenic over-expression experiments and d) by testing its expression in several normal mouse and normal and neoplastic human tissues. The above experiments have shown that: • FKLF1 is a transcriptional repressor of hemopoiesis that, when over-expressed in transgenic mice, inhibits both erythroid maturation beyond the proerythroblast stage and other hemopoietic cell line proliferation and/or maturation. It also increases human erythroid γ globin expression in vitro and in vivo in adult mice after progenitor transduction via a retroviral vector which is a proof of principle that a transcription factor could prove useful in gene therapy of the hemoglobinopathies. However it does not seem to have a physiologic role in β globin gene locus control, as shown in the transgenic over-expression and gene knockout mouse models. Moreover it appears to be redundant for most mouse tissues, where it is normally expressed, since its absence has little or no consequence both in mouse development and survival as in hematologic parameters and resistance to oncogenic stimuli (e.g. ionizing irradiation). Our tissue expression analysis showed that: i) It is stably expressed in the peripheral blood of healthy blood donors. ii) There is no difference in its expression between normal and neoplastic tissue samples from patients with lung cancer. iii) Most interestingly, it is frequently absent or seriously reduced in the bone marrow of human acute lymphoblastic leukemia of children, where its role must be further elucidated.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gavriilidis, G.
- Γαβριηλίδης, Γεώργιος
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19463